Pulmatrix (PULM) Common Equity (2013 - 2026)
Pulmatrix's Common Equity came in at $2.56 million for Q2 2026, down 54.4% from $5.6 million a year earlier and down 28.8% from the prior quarter.
Powered by 
Analysis
Pulmatrix (PULM) Common Equity (2013 - 2026) Analysis & Trends
At the end of FY2025, Pulmatrix's Common Equity was $3.81 million, down 57.4% from FY2024.
- Common Equity has declined in each of the last four years, with a five-year compound annual growth rate of -30.3% (FY2020 to FY2025).
- Going back by year, Common Equity was $8.95 million in FY2024 (-50.3%), $18 million in FY2023 (-42.2%), $31.11 million in FY2022 (-34.4%) and $47.45 million in FY2021 (+105.1%).
- The Q2 2026 figure represents the lowest quarterly Common Equity since Q4 2014.
- Year-over-year, Common Equity has declined for 18 consecutive quarters, with an average decline of 54.2% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q4 2021 (growth of 105.1%), and the weakest in Q1 2025 (a decline of 62.4%).
- Business Quant data shows PULM's Common Equity at $3.59 million (Q1 2026), $3.81 million (Q4 2025) and $4.73 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Pulmatrix | 5.55 Mn | 5.55 Mn | - | 2.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.56 Mn |
| Mar 31, 2026 | 3.59 Mn |
| Dec 31, 2025 | 3.81 Mn |
| Sep 30, 2025 | 4.73 Mn |
| Jun 30, 2025 | 5.60 Mn |
| Mar 31, 2025 | 7.15 Mn |
| Dec 31, 2024 | 8.95 Mn |
| Sep 30, 2024 | 10.92 Mn |
| Jun 30, 2024 | 13.31 Mn |
| Mar 31, 2024 | 19.02 Mn |
| Dec 31, 2023 | 18.00 Mn |
| Sep 30, 2023 | 19.88 Mn |
| Jun 30, 2023 | 23.45 Mn |
| Mar 31, 2023 | 27.01 Mn |
| Dec 31, 2022 | 31.11 Mn |
| Sep 30, 2022 | 35.05 Mn |
| Jun 30, 2022 | 38.44 Mn |
| Mar 31, 2022 | 42.76 Mn |
| Dec 31, 2021 | 47.45 Mn |
| Sep 30, 2021 | 45.19 Mn |
API Access
Pulmatrix Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PULM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PULM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PULM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();